Abstract 4100: Mechanisms of resistance to type I and type II MET inhibitors in non-small cell lung cancer

Mapping Intimacies ◽

10.1158/1538-7445.am2017-4100 ◽

2017 ◽

Author(s):

Magda Bahcall ◽

Yanan Kuang ◽

Cloud P. Paweletz ◽

Pasi A. Jänne

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Type I ◽

Type Ii ◽

Small Cell Lung ◽

Mechanisms Of Resistance

Download Full-text

Protein kinase G type-I phosphorylates c-Src at serine-17 and promotes cell survival, proliferation and attachment in human mesothelioma and non-small cell lung cancer cells

BMC Pharmacology ◽

10.1186/1471-2210-11-s1-o31 ◽

2011 ◽

Vol 11 (S1) ◽

Author(s):

Ronald R Fiscus ◽

Mary G Johlfs

Keyword(s):

Lung Cancer ◽

Protein Kinase ◽

Small Cell Lung Cancer ◽

Cell Survival ◽

Cancer Cells ◽

Cell Lung Cancer ◽

Protein Kinase G ◽

Type I ◽

Small Cell Lung

Download Full-text

Mechanisms of resistance after crizotinib or second-generation ALK therapy in advanced non-small cell lung cancer

Precision Cancer Medicine ◽

10.21037/pcm-20-33 ◽

2021 ◽

Vol 0 ◽

pp. 0-0

Author(s):

Jordi Remon ◽

Laura Esteller ◽

Lizza E. L. Hendriks

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Second Generation ◽

Small Cell Lung ◽

Mechanisms Of Resistance

Download Full-text

Mechanisms of Resistance to Target Therapies in Non-small Cell Lung Cancer

Mechanisms of Drug Resistance in Cancer Therapy - Handbook of Experimental Pharmacology ◽

10.1007/164_2017_16 ◽

2017 ◽

pp. 63-89 ◽

Author(s):

Francesco Facchinetti ◽

Claudia Proto ◽

Roberta Minari ◽

Marina Garassino ◽

Marcello Tiseo

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

Mechanisms Of Resistance ◽

Target Therapies

Download Full-text

Mechanisms of resistance to selective RET tyrosine kinase inhibitors in RET fusion-positive non-small-cell lung cancer

Annals of Oncology ◽

10.1016/j.annonc.2020.09.015 ◽

2020 ◽

Vol 31 (12) ◽

pp. 1725-1733 ◽

Author(s):

J.J. Lin ◽

S.V. Liu ◽

C.E. McCoach ◽

V.W. Zhu ◽

A.C. Tan ◽

...

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Tyrosine Kinase Inhibitors ◽

Cell Lung Cancer ◽

Kinase Inhibitors ◽

Small Cell Lung ◽

Mechanisms Of Resistance

Download Full-text

Interaction with Type II Estrogen Binding Sites and Antiproliferative Activity of Tamoxifen and Quercetin in Human Non-Small-Cell Lung Cancer

American Journal of Respiratory Cell and Molecular Biology ◽

10.1165/ajrcmb.17.1.2728 ◽

1997 ◽

Vol 17 (1) ◽

pp. 51-59 ◽

Author(s):

Sara Caltagirone ◽

Franco O. Ranelletti ◽

Alessandro Rinelli ◽

Nicola Maggiano ◽

Antonella Colasante ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Antiproliferative Activity ◽

Binding Sites ◽

Type Ii ◽

Small Cell Lung ◽

Estrogen Binding

Download Full-text

P3.01-037 Understanding Mechanisms of Resistance to Osimertinib by Circulating Tumor DNA Genotyping in Advanced Non-Small-Cell Lung Cancer

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2017.09.1478 ◽

2017 ◽

Vol 12 (11) ◽

pp. S2214-S2215 ◽

Author(s):

Y. Du ◽

W. Zang ◽

G. Wang ◽

Y. Sang ◽

F. Gai ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Circulating Tumor Dna ◽

Small Cell Lung ◽

Mechanisms Of Resistance ◽

Dna Genotyping ◽

Download Full-text

Clinical Significance of the Serum Crosslinked N-Telopeptide of Type I Collagen as a Prognostic Marker for Non–Small-Cell Lung Cancer

Clinical Lung Cancer ◽

10.1016/j.cllc.2012.03.012 ◽

2013 ◽

Vol 14 (1) ◽

pp. 50-54 ◽

Author(s):

Motohiro Tamiya ◽

Masashi Kobayashi ◽

Osamu Morimura ◽

Tomomi Yasue ◽

Takashi Nakasuji ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Clinical Significance ◽

Prognostic Marker ◽

Cell Lung Cancer ◽

Type I Collagen ◽

Type I ◽

Small Cell Lung

Download Full-text

11P Senescent immune phenotype (SIP) status that predicts resistance to immune checkpoint blockers (ICB) among CMV+ advanced non-small cell lung cancer (aNSCLC) patients is not associated with chronic type I IFN signature

Annals of Oncology ◽

10.1016/j.annonc.2021.10.027 ◽

2021 ◽

Vol 32 ◽

pp. S1379

Author(s):

M. Naigeon ◽

C. de Oliveira ◽

F-X. Danlos ◽

B. Duchemann ◽

P. Saulnier ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Immune Checkpoint ◽

Type I ◽

Small Cell Lung ◽

Chronic Type ◽

Immune Checkpoint Blockers

Download Full-text

MA09.11 Mechanisms of Resistance to MET Tyrosine Kinase Inhibitors in Patients with MET Exon 14 Mutant Non-Small Cell Lung Cancer

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2019.08.573 ◽

2019 ◽

Vol 14 (10) ◽

pp. S285 ◽

Author(s):

G. Recondo ◽

M. Bahcall ◽

L. Sholl ◽

G. Leonardi ◽

B. Ricciuti ◽

...

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Tyrosine Kinase Inhibitors ◽

Cell Lung Cancer ◽

Kinase Inhibitors ◽

Small Cell Lung ◽

Mechanisms Of Resistance

Download Full-text

Circulating Tumor DNA Genomics Reveal Potential Mechanisms of Resistance to BRAF-Targeted Therapies in Patients with BRAF-Mutant Metastatic Non–Small Cell Lung Cancer

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-20-1037 ◽

2020 ◽

Vol 26 (23) ◽

pp. 6242-6253 ◽

Author(s):

Sandra Ortiz-Cuaran ◽

Laura Mezquita ◽

Aurélie Swalduz ◽

Mihalea Aldea ◽

Julien Mazieres ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Targeted Therapies ◽

Circulating Tumor Dna ◽

Small Cell Lung ◽

Mechanisms Of Resistance ◽

Braf Mutant ◽

Download Full-text